Theratechnologies Inc. (TSE:TH - Get Free Report)'s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$4.47 and traded as high as C$4.53. Theratechnologies shares last traded at C$4.47, with a volume of 35,472 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Jones Trading lowered shares of Theratechnologies from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 3rd. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy".
Check Out Our Latest Analysis on TH
Theratechnologies Price Performance
The stock's 50-day moving average price is C$4.47 and its 200-day moving average price is C$3.75. The company has a market capitalization of C$205.53 million, a price-to-earnings ratio of -23.53, a price-to-earnings-growth ratio of -8.50 and a beta of 0.26. The company has a quick ratio of 0.64, a current ratio of 1.08 and a debt-to-equity ratio of -293.92.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
